Lau Associates’s T2 Biosystems, Inc TTOO Stock Holding History

Lau Associates’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3	Closed	-$32K	–	98
2019 Q3	$32K	Hold	3	–	–	0.02%	94
2019 Q2	$21K	Hold	3	–	–	0.01%	93
2019 Q1	$33K	Buy	+3	New	+$51K	0.02%	91

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lau Associates's TTOO Position: Q4 2019 in Review

Lau Associates sold out of T2 Biosystems, Inc (TTOO) in Q4 2019, closing a stake of 3 shares — an estimated $32K sold.

Lau Associates first reported a position in TTOO in Q1 2019 and held it in 3 quarters. The position peaked at $33K in Q1 2019. 43 funds tracked by Wall St. Rank hold TTOO as of Q4 2019.

Lau Associates reported no remaining T2 Biosystems, Inc position as of Q4 2019 after selling out during the quarter.
Lau Associates sold 3 T2 Biosystems, Inc shares in Q4 2019, an estimated $32K.
Lau Associates first reported a position in T2 Biosystems, Inc in Q1 2019 and held it in 3 quarters.
Lau Associates's T2 Biosystems, Inc position peaked at $33K in Q1 2019.
43 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.